has obtained a CE mark for its QIAstat-Dx Respiratory 4 Plex Flu A-B/RSV/SARS-CoV-2 test, which is intended to be used on the QIAstat-Dx system. The newly launched polymerase chain reaction (PCR) multiplex test can rapidly detect and distinguish between influenza A and B, respiratory syncytial virus (RSV) and Covid-19 infections. Using the simple QIAstat-Dx modular cartridge-based system, the test provides rapid results in nearly one hour without needing further preparation of the sample.
and have suspended the marketing of certain Covid-19 tests in the UK following the ³Ô¹ÏºÚÁÏÍøs (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 of the UK Health Security Agency coming into effect. Avacta has halted the sales of its AffiDX SARS-CoV-2 Lateral Flow Rapid Antigen Test in the country until the agency concludes the desktop evaluation. Novacyt will now only market its PROmate COVID-19 test while the authority reviews its other nine tests.
Semiconductor supplier has ramped up production of a synchronous boost converter solution used with Lucira Health’s at-home Covid-19 test, due to anticipated high demand. The single-use Lucira COVID-19 All-In-One Test Kit obtained Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) in November last year. It has a ‘swab, stir and detect’ design to deliver a positive or negative result in the at-home setting in just 30 minutes.
